BACKGROUND: Thymoquinone (TQ), an active ingredient of the seed oil extract of Nigella sativa Linn, has previously been shown to possess antitumor, antioxidant, and anti-inflammatory bioactivity. Whether TQ has any effect on colitis remains controversial. AIM: The aim of this study was to determine whether treatment with TQ prevents and ameliorates colonic inflammation in a mouse model of inflammatory bowel disease. METHODS: C57BL/6 murine colitis was induced by the administration of dextran sodium sulfate (DSS) (3 % W/V) in the drinking water supplied to the mice for 7 consecutive days. The mice with colitis were treated with 5, 10, or 25 mg/kg TQ orally, and changes in body weight and macroscopic and microscopic colitis scores were examined. In addition, biochemical analyses were conducted. RESULTS: The treatment of mice with TQ prevented and significantly reduced the appearance of diarrhea and body weight loss. These results were associated with amelioration of colitis-related damage, as measured by macroscopic and microscopic colitis scores. In addition, there was a significant reduction in colonic myeloperoxidase activity and malondialdehyde levels and an increase in glutathione levels. CONCLUSIONS: These results indicate that TQ administration can prevent and improve murine DSS-induced colitis. These findings suggest that TQ could serve as a potential therapeutic agent for the treatment of patients with inflammatory bowel disease.
BACKGROUND:Thymoquinone (TQ), an active ingredient of the seed oil extract of Nigella sativa Linn, has previously been shown to possess antitumor, antioxidant, and anti-inflammatory bioactivity. Whether TQ has any effect on colitis remains controversial. AIM: The aim of this study was to determine whether treatment with TQ prevents and ameliorates colonic inflammation in a mouse model of inflammatory bowel disease. METHODS: C57BL/6 murinecolitis was induced by the administration of dextran sodium sulfate (DSS) (3 % W/V) in the drinking water supplied to the mice for 7 consecutive days. The mice with colitis were treated with 5, 10, or 25 mg/kg TQ orally, and changes in body weight and macroscopic and microscopic colitis scores were examined. In addition, biochemical analyses were conducted. RESULTS: The treatment of mice with TQ prevented and significantly reduced the appearance of diarrhea and body weight loss. These results were associated with amelioration of colitis-related damage, as measured by macroscopic and microscopic colitis scores. In addition, there was a significant reduction in colonic myeloperoxidase activity and malondialdehyde levels and an increase in glutathione levels. CONCLUSIONS: These results indicate that TQ administration can prevent and improve murineDSS-induced colitis. These findings suggest that TQ could serve as a potential therapeutic agent for the treatment of patients with inflammatory bowel disease.
Authors: Sanjeev Banerjee; Subhash Padhye; Asfar Azmi; Zhiwei Wang; Philip A Philip; Omer Kucuk; Fazlul H Sarkar; Ramzi M Mohammad Journal: Nutr Cancer Date: 2010 Impact factor: 2.900
Authors: Ulrich Kalus; Axel Pruss; Jaromir Bystron; Moric Jurecka; Alice Smekalova; Johannes Josef Lichius; Holger Kiesewetter Journal: Phytother Res Date: 2003-12 Impact factor: 5.878
Authors: Ahmed O Kaseb; Kannagi Chinnakannu; Di Chen; Arun Sivanandam; Sheela Tejwani; Mani Menon; Q Ping Dou; G Prem-Veer Reddy Journal: Cancer Res Date: 2007-08-15 Impact factor: 12.701
Authors: Aftab Ahmad; Asif Husain; Mohd Mujeeb; Shah Alam Khan; Abul Kalam Najmi; Nasir Ali Siddique; Zoheir A Damanhouri; Firoz Anwar Journal: Asian Pac J Trop Biomed Date: 2013-05
Authors: J Rafael Montenegro-Burke; Bernard P Kok; Carlos Guijas; Xavier Domingo-Almenara; Clara Moon; Andrea Galmozzi; Seiya Kitamura; Lars Eckmann; Enrique Saez; Gary E Siuzdak; Dennis W Wolan Journal: Sci Signal Date: 2021-09-28 Impact factor: 8.192
Authors: Shahida A Khan; Aziz M Khan; Sajjad Karim; Mohammad Amjad Kamal; Ghazi A Damanhouri; Zeenat Mirza Journal: Saudi J Biol Sci Date: 2014-10-13 Impact factor: 4.219